// App-Quantinova.ai

Mo1999 : Orally Administered Nanoparticles of Heparins From Marine Invertebrates Attenuate Experimental Colitis

Researchers

Presenter

  • Anna Paola T. Pierucci

Principal Investigators

  • Morgana T. Castelo-Branco

  • Mauro Sergio G. Pavao

  • Heitor S. Souza

Medical Centers

  • Federal University of Rio de Janeiro, Rio de Janeiro, Brazil

Locations

  • Brazil

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Inflammatory bowel disease

  • Deep vein thrombosis

  • Venous thrombosis

  • Ulcerative colitis

Biomarkers

  • Interleukin 1

Drug/Treatment

  • Heparin

Outcome

  • Unknown

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved